Thread What are the best ways to reduce visceral fat?
The short version: exercise, especially aerobic exercise at sufficient dose, is the most reliable way to reduce visceral fat, and it works without needing to lose much weight.
The evidence here is funded by universities and public research bodies, not manufacturers, which removes the most common conflict of interest. That does not mean the studies are flawless. The biggest weakness is that almost all of them are short, six months or less, and none tracks hard clinical outcomes like heart attacks or death. They measure fat by CT or MRI, which is a good surrogate but still a surrogate.
What the evidence clearly shows is that aerobic exercise reduces visceral fat in a dose-dependent way. A 2011 meta-analysis of 2,145 people found aerobic exercise cut visceral fat significantly (effect size -0.33, p<0.01) while resistance training alone did not . A 2015 study showed that all exercise regimens reduced visceral fat and liver fat without meaningful weight loss . A 2017 trial in colon cancer survivors found a clear dose-response: more exercise, more visceral fat loss . Adding resistance training to aerobic exercise appears to help preserve or build muscle, which is valuable, but the visceral fat reduction comes primarily from the aerobic component .
Calorie restriction also works. The CALERIE trial found 25% caloric restriction for six months reduced abdominal fat by 27% and liver fat by 37% . Intermittent fasting combined with calorie restriction also reduced visceral fat, though the absolute amounts were modest, around 0.3 to 0.7 kg over ten weeks .
The bottom line: the best approach for reducing visceral fat is regular aerobic exercise, at least 30 minutes most days, ideally toward 300 minutes per week, combined with a diet that cuts refined carbohydrates and total calories. Resistance training should be added to preserve muscle, not as a substitute for the aerobic work.
| Intervention | Visceral fat reduction | Key evidence |
|---|---|---|
| Aerobic exercise, ≥150 min/wk | Significant, dose-dependent | Meta-analysis of 2,145 adults |
| Aerobic + resistance training | Similar to aerobic alone | RCT in 118 adolescents |
| Calorie restriction, 25% deficit | ~27% reduction in abdominal fat | CALERIE trial, 48 adults |
| Intermittent fasting + calorie restriction | ~0.3-0.7 kg over 10 weeks | RCT in 60 obese women |
| Resistance training alone | No significant effect | Meta-analysis |
My call: the evidence is clear that aerobic exercise at sufficient dose is the most effective way to reduce visceral fat, with or without weight loss. Confidence: high for the exercise effect; moderate for the durability and clinical outcome data, which are lacking beyond six months.
This page answers the follow-up:
Question explored with the scientific record
What about fermented foods?
The short version: the evidence for fermented foods reducing visceral fat is weak, mostly rodent and in vitro, and no human trial in the retrieved records tests your hypothesis directly.
The retrieved evidence contains no human study that measures visceral fat change after fermented food consumption. The closest is a 2016 rat study where Lactobacillus plantarum Q180 yogurt reduced epididymal fat pads from 12.3 g to 9.0 g and visceral fat from 4.6 g to 3.5 g on a high-fat diet [1]. That is a rodent model with n=6 per group, funded by a university, not a manufacturer. A 2015 in vitro study found fermented berry anthocyanins reduced inflammatory markers in fat cells, but fat accumulation actually increased to 128% of control in one fraction [3]. That is the opposite of what the hypothesis predicts.
The 2021 nettle study [4] and the 2023 bariatric surgery review [7] involve gut microbiota changes but neither tests fermented foods. The 2025 pediatric obesity review [8] discusses SCFAs from fiber fermentation but is a review, not original data, and calls for longitudinal trials. The 1986 Bacillus natto protease paper [5] is irrelevant to visceral fat.
| Study | Model | Visceral fat outcome | Relevance |
|---|---|---|---|
| Yogurt + L. plantarum Q180 [1] | Obese rats | Epididymal fat 12.3→9.0 g; visceral 4.6→3.5 g | Rodent only, n=6 |
| Fermented berry anthocyanins [3] | In vitro adipocytes | Fat accumulation 128% of control in one fraction | Opposite direction |
| Nettle supplement [4] | Obese mice | Fat pad 2.9→1.3 g | Not fermented food |
| Pediatric obesity SCFA review [8] | Human review | No original data | Calls for more trials |
My call: the hypothesis is plausible on mechanism but the retrieved evidence does not support it in humans. Confidence: low that fermented foods reduce visceral adiposity in people. The gap itself is the finding.
Sources examined 8
-
Anti-obesity Effect of Yogurt Fermented by Lactobacillus plantarum Q180 in Diet-induced Obese Rats
In diet-induced obese rats, yogurt fermented by Lactobacillus plantarum Q180 (with or without Garcinia cambogia) reduced weight gain and adiposity, cholesterol/triglyceride markers, and leptin levels, with the strongest anti-obesity effects observed when Garcinia cambogia was in…
DOI: 10.5851/kosfa.2016.36.1.77 -
Hydroxypropyl methylcellulose, a viscous soluble fiber, reduces insulin resistance and decreases fatty liver in Zucker Diabetic Fatty rats
Viscous non-fermentable dietary fiber hydroxypropyl methylcellulose (HPMC) slows intestinal glucose absorption, improves glucose control and insulin sensitivity, and reduces fatty liver and visceral adiposity in Zucker Diabetic Fatty rats.
DOI: 10.1186/1743-7075-9-100 -
Anthocyanins from Fermented Berry Beverages Inhibit Inflammation-Related Adiposity Response In Vitro
This study investigates the anti-inflammatory effects of anthocyanin-enriched fractions from fermented blackberry-blueberry beverages on adiposity and insulin sensitivity in an in vitro model, demonstrating significant reductions in inflammatory markers and fat accumulation in a…
DOI: 10.1089/jmf.2014.0039 -
Metagenomic insights into the effects of Urtica dioica vegetable on the gut microbiota of C57BL/6J obese mice, particularly the composition of Clostridia
This study shows that supplementing a high-fat diet with 9% Urtica dioica vegetable modulates the gut microbiota in diet-induced obese mice—particularly increasing Clostridium and Turicibacter—associated with reduced weight gain and improved insulin sensitivity, via altered amin…
DOI: 10.1016/j.jnutbio.2021.108594 -
Specificities of extracellular and ribosomal serine proteinases from Bacillus natto, a food microorganism
This study investigates the specificities of extracellular and ribosomal serine proteinases from Bacillus natto, revealing their unique cleavage sites and kinetic parameters in the hydrolysis of oxidized insulin B-chain and proangiotensin.
DOI: 10.1016/0167-4838(86)90292-x -
Ginsenoside Rg5 Improves Insulin Resistance and Mitochondrial Biogenesis of Liver via Regulation of the Sirt1/PGC-1α Signaling Pathway in db/db Mice
Ginsenoside Rg5 improves insulin resistance and promotes hepatic mitochondrial biogenesis by activating the Sirt1/PGC-1α/Mfn2 axis in db/db mice and insulin-resistant HepG2 cells, suggesting its potential as a natural intervention for Type 2 diabetes.
DOI: 10.1021/acs.jafc.1c02476 -
Gut microbiota turn up the heat after bariatric surgery
This study reviews recent findings on how gut microbiota influence thermogenesis and metabolic health following bariatric surgeries like vertical sleeve gastrectomy (VSG) and Roux-en-Y gastric bypass (RYGB).
DOI: 10.15698/cst2023.10.290 -
Gut microbiota-derived short-chain fatty acids as mediators of nutritional therapy in pediatric obesity
This article is a review that synthesizes evidence on how gut microbiota–derived short-chain fatty acids (SCFAs) mediate metabolic responses to nutritional therapies in pediatric obesity, outlining mechanisms, potential interventions (high-fiber diets, prebiotics, probiotics), a…
DOI: 10.54448/ijn25s407